T

Talkmed Group Ltd
SGX:5G3

Watchlist Manager
Talkmed Group Ltd
SGX:5G3
Watchlist
Price: 0.44 SGD -2.22% Market Closed
Market Cap: 584.2m SGD
Have any thoughts about
Talkmed Group Ltd?
Write Note

Operating Margin
Talkmed Group Ltd

41.5%
Current
46%
Average
4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
41.5%
=
Operating Profit
32.8m
/
Revenue
79.1m

Operating Margin Across Competitors

Country SG
Market Cap 583.7m SGD
Operating Margin
41%
Country US
Market Cap 91.8B USD
Operating Margin
4%
Country US
Market Cap 87.7B EUR
Operating Margin
4%
Country US
Market Cap 73B USD
Operating Margin
3%
Country DE
Market Cap 24.9B EUR
Operating Margin
7%
Country US
Market Cap 20.1B USD
Operating Margin
9%
Country DE
Market Cap 18.8B EUR
Operating Margin
7%
Country US
Market Cap 18.3B USD
Operating Margin
14%
Country US
Market Cap 13.7B USD
Operating Margin
15%
Country DE
Market Cap 12.4B EUR
Operating Margin
7%
Country AU
Market Cap 13.4B AUD
Operating Margin
9%
No Stocks Found

Talkmed Group Ltd
Glance View

Market Cap
583.7m SGD
Industry
Health Care

TalkMed Group Ltd. is an investment holding company, which engages in the provision of medical oncology, stem cell transplants, and palliative care services. The firm is a provider of medical oncology and palliative care health care services in Singapore. The firm operates through two segments: Oncology services, and Cellular and gene therapy related products and services. The Oncology services provide specialist doctors and clinical staff to Parkway Cancer Centre (PCC), a division of Parkway Hospitals Singapore Pte. Ltd. for the provision of specialist medical oncology services (consultancy services). The company also provides consultancy services to Thu Cuc International General Hospital (TCH), to enable TCH to operate a medical center for the provision of oncology services in Hanoi, Vietnam. The company also provides consultancy services to the patients in Beijing and Chongqing. Cellular and gene therapy-related products and services include the provision of goods and services related to cellular and gene therapy through its subsidiary, CellVec Pte. Ltd. (CellVec).

5G3 Intrinsic Value
0.31 SGD
Overvaluation 30%
Intrinsic Value
Price
T

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
41.5%
=
Operating Profit
32.8m
/
Revenue
79.1m
What is the Operating Margin of Talkmed Group Ltd?

Based on Talkmed Group Ltd's most recent financial statements, the company has Operating Margin of 41.5%.